Literature DB >> 31186886

Histopathologic features of hepatocellular carcinoma.

Elizabeth M Brunt1.   

Abstract

Entities:  

Year:  2013        PMID： 31186886      PMCID： PMC6499305          DOI： 10.1002/cld.98

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


× No keyword cloud information.
  15 in total

1.  Annexin A2 as a differential diagnostic marker of hepatocellular tumors.

Authors:  Thomas Longerich; Maria Theresia Haller; Carolin Mogler; Sebastian Aulmann; Volker Lohmann; Peter Schirmacher; Karsten Brand
Journal:  Pathol Res Pract       Date:  2010-10-23       Impact factor: 3.250

Review 2.  Pathology of early hepatocellular carcinoma: conventional and molecular diagnosis.

Authors:  Tania Roskams; Masamichi Kojiro
Journal:  Semin Liver Dis       Date:  2010-02-19       Impact factor: 6.115

3.  The application of markers (HSP70 GPC3 and GS) in liver biopsies is useful for detection of hepatocellular carcinoma.

Authors:  Luca Di Tommaso; Annarita Destro; Jae Yeon Seok; Emanuela Balladore; Luigi Terracciano; Angelo Sangiovanni; Massimo Iavarone; Massimo Colombo; Ja June Jang; Eunsil Yu; So Young Jin; Emanuela Morenghi; Young Nyun Park; Massimo Roncalli
Journal:  J Hepatol       Date:  2008-12-25       Impact factor: 25.083

4.  Ductular reaction is helpful in defining early stromal invasion, small hepatocellular carcinomas, and dysplastic nodules.

Authors:  Young Nyun Park; Masamichi Kojiro; Luca Di Tommaso; Amar P Dhillon; Fukuo Kondo; Masayuki Nakano; Michiie Sakamoto; Neil D Theise; Massimo Roncalli
Journal:  Cancer       Date:  2007-03-01       Impact factor: 6.860

5.  Classification tool for the systematic histological assessment of hepatocellular carcinoma, macroregenerative nodules, and dysplastic nodules in cirrhotic liver.

Authors:  A Quaglia; M A Jutand; A Dhillon; A Godfrey; R Togni; P Bioulac-Sage; C Balabaud; M Winnock; A P Dhillon
Journal:  World J Gastroenterol       Date:  2005-10-28       Impact factor: 5.742

6.  Revisiting the pathology of resected benign hepatocellular nodules using new immunohistochemical markers.

Authors:  Paulette Bioulac-Sage; Gaelle Cubel; Charles Balabaud; Jessica Zucman-Rossi
Journal:  Semin Liver Dis       Date:  2011-02-22       Impact factor: 6.115

7.  Histopathological classification of hepatocellular carcinoma.

Authors:  Massimo Roncalli; Young Nyun Park; Luca Di Tommaso
Journal:  Dig Liver Dis       Date:  2010-07       Impact factor: 4.088

8.  Diagnostic value of HSP70, glypican 3, and glutamine synthetase in hepatocellular nodules in cirrhosis.

Authors:  Luca Di Tommaso; Giada Franchi; Young Nyun Park; Barbara Fiamengo; Annarita Destro; Emanuela Morenghi; Marco Montorsi; Guido Torzilli; Maurizio Tommasini; Luigi Terracciano; Luigi Tornillo; Raffaella Vecchione; Massimo Roncalli
Journal:  Hepatology       Date:  2007-03       Impact factor: 17.425

Review 9.  Early hepatocellular carcinoma and dysplastic nodules.

Authors:  Masamichi Kojiro; Tania Roskams
Journal:  Semin Liver Dis       Date:  2005       Impact factor: 6.115

10.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425
View more
  1 in total

1.  1,8 Cineole and Ellagic acid inhibit hepatocarcinogenesis via upregulation of MiR-122 and suppression of TGF-β1, FSCN1, Vimentin, VEGF, and MMP-9.

Authors:  Heba M I Abdallah; Sally A El Awdan; Rehab F Abdel-Rahman; Abdel Razik H Farrag; Rasha M Allam
Journal:  PLoS One       Date:  2022-01-26       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.